World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0026620757
Reproduction Date:

Title: 4-Methylmethylphenidate  
Author: World Heritage Encyclopedia
Language: English
Subject: 3,4-Dichloromethylphenidate, HDMP-28, Designer drugs, Caffeine, Isoethcathinone
Collection: Carboxylate Esters, Designer Drugs, Methyl Esters, Piperidines, Stimulants
Publisher: World Heritage Encyclopedia


Systematic (IUPAC) name
methyl (2R)-2-(4-methylphenyl)-2-[(2R)-piperidin-2-yl]acetate
Clinical data
Legal status
ATC code ?
ChemSpider  YesY
Chemical data
Formula C15H21NO2 
Mol. mass 247.332 g/mol

threo-4-Methylmethylphenidate (4-MeTMP) is a stimulant drug related to methylphenidate. It is slightly less potent than methylphenidate and has relatively low efficacy at blocking dopamine reuptake despite its high binding affinity, which led to its investigation as a possible substitute drug for treatment of stimulant abuse (cf. nocaine).[1] On the other hand several other simple ring-substituted derivatives of threo-methylphenidate such as the 4-fluoro and 3-chloro compounds are more potent than methylphenidate both in efficacy as dopamine reuptake inhibitors and in animal drug discrimination assays.[2][3][4]

4-fluoromethylphenidate (4-FTMP) and 3-chloromethylphenidate (3-CTMP)

See also


  1. ^ Wayment, H. K.; Deutsch, H.; Schweri, M. M.; Schenk, J. O. (1999). "Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists?". Journal of Neurochemistry 72 (3): 1266–1274.  
  2. ^ Deutsch, H.; Shi, Q.; Gruszecka-Kowalik, E.; Schweri, M. (1996). "Synthesis and pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs".  
  3. ^ Schweri, M. M.; Deutsch, H. M.; Massey, A. T.; Holtzman, S. G. (2002). "Biochemical and behavioral characterization of novel methylphenidate analogs". The Journal of Pharmacology and Experimental Therapeutics 301 (2): 527–535.  
  4. ^ Davies, H.; Hopper, D.; Hansen, T.; Liu, Q.; Childers, S. (2004). "Synthesis of methylphenidate analogues and their binding affinities at dopamine and serotonin transport sites". Bioorganic & Medicinal Chemistry Letters 14 (7): 1799–1802.  
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.